What this means
This is a trial that has been registered and is now recruiting people. No results have been posted yet, so we cannot say what it found. It shows the plan is to test several screening changes one at a time.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site, including Colorado
The science
- Registered title
- Health Ahead Comparative Effectiveness Study
- Trial ID
- NCT07669168 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Health Services Accessibility, Rural Health, Medically Underserved Area, Preventive Health Services, Patient Participation, Health Behavior, Aging, Cardiovascular Diseases, Metabolic Syndrome, Cognitive Dysfunction, Frailty, Activities of Daily Living, Health Related Quality of Life, Health Equity, Telemedicine
- What is tested
- AI-Assisted Screening Interpretation (AI Reads), Human-Only Screening Interpretation
- Sponsor
- William Brandenburg, MD
- Ages
- 18 Years to no maximum
- Dates
- First posted Jun 25, 2026 · updated Sep 8, 2026
Registry summary
The Health Ahead Comparative Effectiveness Study is a pragmatic, parallel-arm interventional platform that systematically compares successive changes to preventive health screening on the path toward a fully automated screening system deployable in any environment, including the most isolated and resource-limited communities. Each change is isolated as a single variable against current practice, and every comparison is evaluated with a common set of engagement, behavior-change, experience, cost, and longitudinal outcome measures, so results accumulate on a consistent yardstick across the life of the platform.
The first comparison evaluates AI-assisted versus human-only interpretation ("reads") of screening data. Subsequent pre-planned comparisons, added by protocol amendment, evaluate static versus interactive personalized report delivery; mobile community versus fixed laboratory screening; and a hybrid medical-droid-plus-human delivery model versus human-only screening.
Sites (1)
- Longevity Metrics, Boulder, Colorado, United States